User Fee Agreements

User Fee Agreements (UFAs) are arrangements between a government agency, like the FDA, and certain industries, where companies pay fees to help support the agency's review processes for products, such as drugs or medical devices. These fees enable faster evaluations and approvals, improving the efficiency of bringing new products to market. In exchange for the fees, the agency commits to specific performance targets, like review timelines. UFAs help ensure that the regulatory body has sufficient resources while balancing the need for timely access to new innovations for consumers.